EXAGEN INC. - COMMON S

Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

25 Mar 2021 16:15:47 By Nasdaq GlobeNewswire

Exagen Inc. Announces Pricing of Public Offering of Common Stock

22 Mar 2021 22:01:09 By Nasdaq GlobeNewswire

Exagen Inc. Announces Proposed Public Offering of Common Stock

22 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results

16 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 16, 2021

02 Mar 2021 08:00:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Cowen 41st Annual Health Care Conference

22 Feb 2021 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. To Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

03 Feb 2021 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Partners with Boston’s Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

21 Jan 2021 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results

10 Jan 2021 18:00:00 By Nasdaq GlobeNewswire

Exagen Inc. To Participate in 2021 ICR Conference

05 Jan 2021 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Partners with Oregon’s St. Charles Health System to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

04 Jan 2021 16:05:00 By Nasdaq GlobeNewswire